Is it safe to combine a selective serotonin reuptake inhibitor with selegiline?
Toyama
S C
SC
Iacono
R P
RP
D015057:1-Naphthylamine / Q000031:analogs & derivatives / Q000627:therapeutic use; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005473:Fluoxetine / Q000627:therapeutic use; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D017374:Paroxetine / Q000627:therapeutic use; D012642:Selegiline / Q000627:therapeutic use*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D020280:Sertraline
D015057:1-Naphthylamine; D005473:Fluoxetine; D017374:Paroxetine; D012642:Selegiline; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline